A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of ABT-263 (Navitoclax).
Phase of Trial: Phase I
Latest Information Update: 01 Apr 2014
At a glance
- Drugs Ketoconazole (Primary) ; Navitoclax (Primary)
- Indications Cancer; Haematological malignancies
- Focus Pharmacokinetics
- Sponsors AbbVie
- 17 Dec 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 17 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Oct 2010 Actual initiation date changed from Dec 2009 to Jan 2010 as reported by ClinicalTrials.gov.